Mock M, Schwartz M
J Bacteriol. 1980 May;142(2):384-90. doi: 10.1128/jb.142.2.384-390.1980.
Among 69 ColE3 mutant plasmids selected on the basis of their inability to produce an active colicin, seven (cop-1 to cop-7) were found to bear a mutation affecting the structural gene for colicin. Three of these (cop-1, cop-2 and cop-3) lead to the production of an inactive colicin molecule which has the same molecular weight as wild-type colicin E3 (67,000). These three inactive colicins are still able to interact with the outer membrane receptor. The cop-1 protein retained the ability to inhibit protein synthesis in vitro and therefore seems specifically affected in it ability to penetrate the cell envelope. The cop-2 and cop-3 proteins lost the ability to inhibit protein synthesis in vitro, and activity which is normally associated with the C-terminal part of the colicin molecule. On the basis of this and further evidence, it is suggested that the cop-2 and cop-3 mutations affect the structure of the C-terminal part of the colicin molecule. The other four mutations (cop-4 to cop-7) lead to the production of colicin-related polypeptides of lower molecular weight (29,000 to 45,000) which display a reaction of partial immunological identity with wild-type colicin. These four polypeptides are unable to interact with the cell surface receptor. Three of these mutants are shown to carry a nonsense mutation.
在根据无法产生活性大肠杆菌素而挑选出的69个ColE3突变质粒中,发现有7个(cop - 1至cop - 7)携带影响大肠杆菌素结构基因的突变。其中3个(cop - 1、cop - 2和cop - 3)导致产生一种无活性的大肠杆菌素分子,其分子量与野生型大肠杆菌素E3相同(67,000)。这三种无活性的大肠杆菌素仍能与外膜受体相互作用。cop - 1蛋白保留了在体外抑制蛋白质合成的能力,因此似乎在穿透细胞包膜的能力方面受到了特异性影响。cop - 2和cop - 3蛋白失去了在体外抑制蛋白质合成的能力,而这种活性通常与大肠杆菌素分子的C末端部分相关。基于此及进一步的证据,表明cop - 2和cop - 3突变影响了大肠杆菌素分子C末端部分的结构。其他四个突变(cop - 4至cop - 7)导致产生分子量较低(29,000至45,000)的与大肠杆菌素相关的多肽,这些多肽与野生型大肠杆菌素呈现部分免疫同一性反应。这四种多肽无法与细胞表面受体相互作用。其中三个突变体显示携带无义突变。